You are here

Lundbeck

Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash

Endpoints

Mon, 09/11/17 - 10:20 am

Teva Pharmaceutical

23andMe, Lundbeck unveil mega investigation of genetics' role in depression

BioPharma Dive

Thu, 08/3/17 - 10:58 am

bipolar disorder

major depressive disorder

Tapping into the rare disease market

BioPharma Dive

Fri, 03/10/17 - 09:00 pm

Lundbeck reads last rites on another failed PhIII Alzheimer’s program

Endpoints

Wed, 02/8/17 - 09:26 am

Alzheimer's disease

Drug maker loses appeal of antitrust pay-to-delay case in Europe

Stat/Pharmalot

Fri, 09/9/16 - 10:23 am

antidepressants

FDA rejects bid to market antidepressant to treat foggy thinking

Stat

Tue, 03/29/16 - 11:17 am

antidepressants

Why ViiV Healthcare leads the pharma industry in corporate reputation

BioPharma Dive

Wed, 03/23/16 - 04:23 pm

ViiV Healthcare

FDA panel backs game-changing cognitive claim for Lundbeck antidepressant Brintellix

Fierce Pharma

Thu, 02/4/16 - 09:17 pm

antidepressants

This antidepressant may be no better than cheaper alternatives. But demand could soon soar

Stat

Tue, 02/2/16 - 10:28 am

antidepressants

Takeda Pharmaceuticals

Lundbeck to advance schizophrenia drug solo after taking an ax to early-stage pipeline

Fierce Biotech

Thu, 08/20/15 - 09:14 am

Troubled Lundbeck targets 1,000 layoffs in HQ, commercial revamp

Fierce Pharma

Wed, 08/19/15 - 09:11 am

FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia

BioPharma Dive

Mon, 07/13/15 - 09:51 am

FDA approves Otsuka and Lundbeck's schizophrenia treatment

Yahoo/Reuters

Fri, 07/10/15 - 10:53 pm

Slow Sales Uptake For Brintellix Show The Challenges Facing New Depression Drugs

Forbes

Thu, 06/18/15 - 11:03 am

clinical depression

Former Novo exec Schultz will become a CEO after all—just at another pharma

BioPharma Dive

Thu, 05/7/15 - 11:00 am

11 promising drugs poised to be the next billion-dollar blockbusters

Yahoo/Business Insider

Sat, 03/28/15 - 10:26 am

Lundbeck pulls the plug on its fast-tracked stroke drug

Fierce Biotech

Thu, 12/18/14 - 10:25 am

Lundbeck CEO Leaves After Failing to Report Receiving Shares

Bloomberg

Mon, 11/24/14 - 09:43 am

Avanir Inroads in Alzheimer’s Justify Offers: Real M&A

Bloomberg

Thu, 10/30/14 - 12:22 pm

Alzheimer's disease

Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year

Yahoo

Tue, 06/24/14 - 10:26 am

Chelsea Therapeutics

neurogenic orthostatic hypotension

Pages